Accessibility: Skip TopNav
Figure 3
Adverse Events, Serious Adverse Events and Treatment Emergent Adverse Events in the Placebo, 175 mg bid and 350 mg bid groups in the SARA-INT study
Format
PNG
Source
BIOPHYTIS SA
Downloads
Original
Large
Medium
Small